Mr. Tansey is a managing member of U.S. Venture Partners, a leading Silicon Valley venture capital firm. Mr. Tansey brings significant experience in entrepreneurial, early stage, medical device companies to our NeoChord Board of Directors. Prior to joining USVP, Mr. Tansey was President and CEO of Epicor Medical, a medical device company that developed a minimally invasive treatment for atrial fibrillation and was acquired by St. Jude Medical in 2004. Prior to Epicor, he was President and CEO of Heartport Inc., an innovator of minimally invasive cardiac surgery products. Heartport was acquired by Johnson & Johnson in 2001. Previously, Mr. Tansey served as Vice President, North American Sales for Baxter Edwards’ Cardiovascular products, including heart valves and oxygenators. Mr. Tansey’s educational background includes a B.S. and M.B.A from The College of Notre Dame in Belmont, California.